What is HC Wainwright’s Estimate for CRVS FY2028 Earnings?
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Free Report) – Equities researchers at HC Wainwright lowered their FY2028 earnings per share (EPS) estimates for Corvus Pharmaceuticals in a research report issued on Wednesday, March 26th. HC Wainwright analyst S. Lee now anticipates that the company will post earnings per share of $0.11 for the year, down from […]
